Jounce Therapeutics Inc (JNCE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH464036D
- Pages: 44
- October 2018
- Region : North America
- GlobalData
- Equity Research Report
- Details
- Table Of Content
- Licence Rights
- Section Purchase
- Products and Companies
Details
Summary
Jounce Therapeutics Inc (Jounce) is a clinical stage immunotherapy company that develops therapies that enable the immune system to attack tumors. The company provides JTX-2011, an anti-ICOS monoclonal antibody which stimulates T effector cells to enhance anti-tumor activity; JTX-4014, an anti-PD-1 antibody for combination therapy in tumor eradication. It harnesses its proprietary product engine to gain new insights into cancer immunotherapy and explore multiple mechanisms of action against a broad spectrum of targets. Jounce offers services in the areas of tumor immunology, antibody discovery and optimization and integrated translational capabilities. The company has collaborations with the universities, general hospitals and cancer centers. Jounce is headquartered in Cambridge, Massachusetts, the US.
Jounce Therapeutics Inc (JNCE)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Jounce Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Jounce Therapeutics Raises USD56 Million in Series B Financing 11
Jounce Therapeutics Raises USD 47 Million In Series A Financing 13
Partnerships 14
OncoSec Medical Enters into Agreement with Jounce Therapeutics 14
Celgene Enters into Agreement with Jounce Therapeutics 15
Jounce Therapeutics Enters Into Research Agreement With Adimab 16
Licensing Agreements 17
Jounce Therapeutics Exercises Option for Licensing Agreement with Adimab 17
Jounce Therapeutics Amends Licensing Agreement for JTX-2011 18
Equity Offering 20
Jounce Therapeutics Files Registration Statement to Raise up to USD250 Million in Public Offering of Securities 20
Jounce Therapeutics Files Registration Statement to Raise up to USD280.7 Million in Public Offering of Shares 21
Jounce Therapeutics Raises USD117.12 million in IPO 22
Jounce Therapeutics Raises USD139 Million in Private Placement of Shares 24
Jounce Therapeutics Inc-Key Competitors 25
Jounce Therapeutics Inc-Key Employees 26
Jounce Therapeutics Inc-Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Financial Announcements 28
Aug 09, 2018: Jounce Therapeutics reports second quarter 2018 financial results 28
May 09, 2018: Jounce Therapeutics Reports First Quarter 2018 Financial Results 30
Mar 08, 2018: Jounce Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results 31
Nov 13, 2017: Jounce Therapeutics Reports Third Quarter 2017 Financial Results 33
Aug 09, 2017: Jounce Therapeutics Reports Second Quarter 2017 Financial Results 34
May 09, 2017: Jounce Therapeutics Reports First Quarter 2017 Financial Results 36
Mar 10, 2017: Jounce Therapeutics reports net income for Q4, provides fiscal 2017 guidance 38
Mar 10, 2017: Jounce Therapeutics reports net income for Q4 39
Corporate Communications 40
Dec 14, 2017: Jounce Therapeutics Added to NASDAQ Biotechnology Index 40
Oct 23, 2017: Jounce Therapeutics Appoints Luis A. Diaz, Jr., M.D., to its Board of Directors 41
Aug 15, 2017: Jounce Therapeutics Names Hugh Cole as Chief Business Officer and Head of Corporate Development 42
Mar 31, 2017: Jounce Therapeutics Added to Russell 2000, 3000 and Microcap Indexes 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44
List Of Figure
List of Figures
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Jounce Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
List Of Table
List of Tables
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Jounce Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Jounce Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Jounce Therapeutics Raises USD56 Million in Series B Financing 11
Jounce Therapeutics Raises USD 47 Million In Series A Financing 13
OncoSec Medical Enters into Agreement with Jounce Therapeutics 14
Celgene Enters into Agreement with Jounce Therapeutics 15
Jounce Therapeutics Enters Into Research Agreement With Adimab 16
Jounce Therapeutics Exercises Option for Licensing Agreement with Adimab 17
Jounce Therapeutics Amends Licensing Agreement for JTX-2011 18
Jounce Therapeutics Files Registration Statement to Raise up to USD250 Million in Public Offering of Securities 20
Jounce Therapeutics Files Registration Statement to Raise up to USD280.7 Million in Public Offering of Shares 21
Jounce Therapeutics Raises USD117.12 million in IPO 22
Jounce Therapeutics Raises USD139 Million in Private Placement of Shares 24
Jounce Therapeutics Inc, Key Competitors 25
Jounce Therapeutics Inc, Key Employees 26
Jounce Therapeutics Inc, Subsidiaries 27
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
Products and Companies
Products
Jounce Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Related Reports
Page 181 | 
July 2019
Page 130 | May 2019
Page 155 | April 2019
Page 159 | March 2019
Page 222 | January 2019